Free Trial

Li-Cycle (LICY) Competitors

Li-Cycle logo
$1.03 +0.02 (+2.18%)
Closing price 03:59 PM Eastern
Extended Trading
$1.02 -0.01 (-0.68%)
As of 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

LICY vs. HAO, HGBL, PHUN, CURR, TETE, YYGH, FORA, WKEY, INUV, and BGSF

Should you be buying Li-Cycle stock or one of its competitors? The main competitors of Li-Cycle include Haoxi Health Technology (HAO), Heritage Global (HGBL), Phunware (PHUN), CURRENC Group (CURR), Technology & Telecommunication Acquisition (TETE), YY Group (YYGH), Forian (FORA), WISeKey International (WKEY), Inuvo (INUV), and BGSF (BGSF). These companies are all part of the "business services" industry.

Li-Cycle vs.

Li-Cycle (NYSE:LICY) and Haoxi Health Technology (NASDAQ:HAO) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, community ranking, risk, institutional ownership, earnings, dividends and analyst recommendations.

In the previous week, Li-Cycle had 6 more articles in the media than Haoxi Health Technology. MarketBeat recorded 11 mentions for Li-Cycle and 5 mentions for Haoxi Health Technology. Haoxi Health Technology's average media sentiment score of 0.57 beat Li-Cycle's score of -0.28 indicating that Haoxi Health Technology is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Li-Cycle
2 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Haoxi Health Technology
0 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Li-Cycle presently has a consensus target price of $4.13, indicating a potential upside of 299.71%. Given Li-Cycle's stronger consensus rating and higher possible upside, analysts clearly believe Li-Cycle is more favorable than Haoxi Health Technology.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Li-Cycle
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Haoxi Health Technology
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

54.1% of Li-Cycle shares are owned by institutional investors. 17.7% of Li-Cycle shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Haoxi Health Technology has lower revenue, but higher earnings than Li-Cycle.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Li-Cycle$18.30M1.31-$138M-$1.25-0.83
Haoxi Health TechnologyN/AN/AN/AN/AN/A

Li-Cycle received 20 more outperform votes than Haoxi Health Technology when rated by MarketBeat users.

CompanyUnderperformOutperform
Li-CycleOutperform Votes
20
35.09%
Underperform Votes
37
64.91%
Haoxi Health TechnologyN/AN/A

Haoxi Health Technology has a net margin of 0.00% compared to Li-Cycle's net margin of -77.74%. Haoxi Health Technology's return on equity of 0.00% beat Li-Cycle's return on equity.

Company Net Margins Return on Equity Return on Assets
Li-Cycle-77.74% -41.90% -13.43%
Haoxi Health Technology N/A N/A N/A

Summary

Li-Cycle beats Haoxi Health Technology on 7 of the 11 factors compared between the two stocks.

Get Li-Cycle News Delivered to You Automatically

Sign up to receive the latest news and ratings for LICY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LICY vs. The Competition

MetricLi-CycleSanitary services IndustryComputer SectorNYSE Exchange
Market Cap$23.96M$2.23B$26.64B$20.35B
Dividend YieldN/A8.71%2.72%3.62%
P/E Ratio-0.836.29236.7942.15
Price / Sales1.312.733,313.5316.67
Price / CashN/A23.4036.0720.36
Price / Book0.0663.598.435.93
Net Income-$138M$38.33M$674.23M$1.01B
7 Day Performance0.68%-2.20%-0.65%0.47%
1 Month Performance-43.91%-20.13%1.98%5.56%
1 Year Performance-70.83%-3.05%22.45%17.41%

Li-Cycle Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LICY
Li-Cycle
2.8343 of 5 stars
$1.03
+2.2%
$4.13
+299.7%
-75.4%$23.96M$18.30M-0.83270News Coverage
Gap Up
High Trading Volume
HAO
Haoxi Health Technology
N/A$2.65
+2,465.3%
N/A-97.9%$85.44MN/A0.0029Stock Split
Short Interest ↓
High Trading Volume
HGBL
Heritage Global
1.895 of 5 stars
$2.15
+2.1%
N/A-26.7%$79.91M$60.54M7.6460Short Interest ↓
News Coverage
Positive News
PHUN
Phunware
1.9852 of 5 stars
$3.97
-6.7%
$13.00
+227.9%
-73.0%$79.87M$4.83M0.00120Short Interest ↑
CURR
CURRENC Group
N/A$1.66
-9.3%
N/AN/A$76.54MN/A0.002Gap Down
TETE
Technology & Telecommunication Acquisition
N/A$12.41
+2.4%
N/A+7.5%$74.18MN/A0.002Positive News
High Trading Volume
YYGH
YY Group
N/A$1.81
-2.2%
N/AN/A$71.36M$37.37M0.00N/AShort Interest ↑
News Coverage
Gap Down
FORA
Forian
2.9458 of 5 stars
$2.20
-1.1%
$5.00
+127.8%
-11.4%$68.08M$19.71M-24.39140Short Interest ↓
News Coverage
Gap Down
High Trading Volume
WKEY
WISeKey International
1.0315 of 5 stars
$7.97
-4.8%
$4.00
-49.8%
+237.9%$65.04M$30.92M0.00140Short Interest ↑
Gap Up
INUV
Inuvo
1.7026 of 5 stars
$0.45
-11.1%
$1.00
+123.7%
+14.2%$62.80M$78.45M-7.4580
BGSF
BGSF
1.2261 of 5 stars
$5.18
-0.1%
N/A-50.2%$57.03M$313.17M-51.74400Analyst Forecast

Related Companies and Tools


This page (NYSE:LICY) was last updated on 1/30/2025 by MarketBeat.com Staff
From Our Partners